Raymond James Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.96M Buy
3,879
+1,561
+67% +$758K 0.04% 327
2024
Q2
$1.13M Sell
2,318
-46
-2% -$23.1K 0.03% 441
2024
Q1
$1.28M Buy
2,364
+9
+0.4% +$4.92K 0.03% 407
2023
Q4
$1.31M Buy
2,355
+288
+14% +$135K 0.03% 389
2023
Q3
$904K Buy
2,067
+4
+0.2% +$2K 0.03% 447
2023
Q2
$1.04M Sell
2,063
-36
-2% -$17.3K 0.03% 424
2023
Q1
$1.05M Buy
2,099
+415
+25% +$199K 0.03% 403
2022
Q4
$687K Sell
1,684
-460
-21% -$179K 0.02% 498
2022
Q3
$699K Buy
2,144
+420
+24% +$154K 0.03% 464
2022
Q2
$605K Buy
1,724
+100
+6% +$40.8K 0.02% 526
2022
Q1
$888K Buy
1,624
+343
+27% +$180K 0.03% 448
2021
Q4
$843K Buy
1,281
+150
+13% +$94.2K 0.03% 474
2021
Q3
$703K Sell
1,131
-194
-15% -$130K 0.02% 498
2021
Q2
$837K Sell
1,325
-61
-4% -$33.7K 0.03% 444
2021
Q1
$678K Buy
1,386
+734
+113% +$368K 0.02% 473
2020
Q4
$326K Buy
+652
New +$292K 0.01% 730
2019
Q4
Sell
-752
Closed -$204K 974
2019
Q3
$204K Buy
+752
New +$209K 0.01% 851
2016
Q3
Sell
-4,322
Closed -$402K 690
2016
Q2
$402K Sell
4,322
-505
-10% -$43.4K 0.04% 383
2016
Q1
$378K Buy
4,827
+1,388
+40% +$99.9K 0.04% 393
2015
Q4
$250K Buy
+3,439
New +$245K 0.02% 529

Other funds holding IDXX

Raymond James Trust's IDXX Position: Q3 2024 in Review

Raymond James Trust increased its Idexx Laboratories (IDXX) stake by 67% in Q3 2024, buying an estimated $758K and bringing the position to 3,879 shares worth $1.96M. The position accounts for 0.04% of the portfolio, ranked #327.

Raymond James Trust first reported a position in IDXX in Q4 2015 and has held it in 20 quarters since. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Raymond James Trust held 3,879 shares of Idexx Laboratories worth $1.96M as of Q3 2024.
  • Raymond James Trust bought 1,561 Idexx Laboratories shares in Q3 2024, an estimated $758K.
  • Idexx Laboratories made up 0.04% of Raymond James Trust's portfolio in Q3 2024, its #327 holding.
  • Raymond James Trust first reported a position in Idexx Laboratories in Q4 2015 and has held it in 20 quarters since.
  • 1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.